²é¿´: 823  |  »Ø¸´: 18
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßxjxlovelxl½«ÔùËÍÄú 57 ¸ö½ð±Ò

xjxlovelxl

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

CA-FANS

[ÇóÖú] [·ÅÆúÇóÖú,Çë°ßÖñɾÌù]¡ô×ö¿¹Ö×Áö×÷ÓûúÖÆ¿ÉÒÔ²éÔÄÄÄЩÍâÎÄÊý¾Ý¿â»ñÈ¡Ïà¹ØÎÄÏסô


ÎÊÌâ1¡¢
×ö¿¹Ö×Áö×÷ÓûúÖÆ¿ÉÒÔ²éÔÄÄÄЩÊý¾Ý¿â»ñÈ¡Ïà¹ØÎÄÏ×


ÎÊÌâ2¡¢
¿ÉÒÔÑ¡ÓÃÄÄЩ°©Ï¸°û×öʵÑ飿


ÎÊÌâ3¡¢
ÄÜ·ñÌṩһЩÏà¹ØÎÄÏ×

                                                                       

[ Last edited by xjxlovelxl on 2008-1-24 at 22:42 ]

» ²ÂÄãϲ»¶

¡¾¹«¸æ£ºÓн±ÎÊ´ð°æ½ûÖ¹¹àË®¡¿
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

asbaggio1977

½ð³æ (ÕýʽдÊÖ)

¡ï ¡ï
xjxlovelxl(½ð±Ò+2,VIP+0):ллÄãµÄ½â´ð£¬Ï£ÍûÄܸüÏ꾡µÄ½éÉÜһϣ¬ÎÒÒÔǰû×ö¹ý£¬ÊǸöÉúÊÖ
cancer letters, cancer research,  J. Med. ChemµÈ
Ö×Áöϸ°ûÖêÌ«¶àÑ¡ÔñÁË¡£
±£³ÖÕæ³Ï£¡
2Â¥2008-01-17 12:35:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

asbaggio1977

½ð³æ (ÕýʽдÊÖ)

³£¼ûһЩµÄ: BEL7402, P388, L1210, KB, CNE1, HCT-116µÈ¡£
±£³ÖÕæ³Ï£¡
3Â¥2008-01-17 12:37:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xjxlovelxl

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

CA-FANS

ÒýÓûØÌû:
Originally posted by asbaggio1977 at 2008-1-17 12:35:
cancer letters, cancer research,  J. Med. ChemµÈ
Ö×Áöϸ°ûÖêÌ«¶àÑ¡ÔñÁË¡£

ÕâЩӦ¸ÃÊÇÔÓÖ¾Ãû°É£¬ÊÇÄĸöÊý¾Ý¿âÀïµÄÄØ£¿
¡¾¹«¸æ£ºÓн±ÎÊ´ð°æ½ûÖ¹¹àË®¡¿
4Â¥2008-01-17 12:39:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Airare

½ð³æ (ÕýʽдÊÖ)

³æÓÎÌìÏÂ

¡ï ¡ï ¡ï ¡ï ¡ï
xjxlovelxl(½ð±Ò+5,VIP+0):ллÄúµÄ°ï棬ÒÔºó»¹Íû¶à¶à´Í½Ì£¡:)
pubmed ,sciencedirect,wileyµÈµÈ¶¼ÊÇÉúÎïÀàÊý¾Ý¿â£¬¿´ÄãÊÇÑо¿Ê²Ã´°©Ö¢£¬¸Î°©£¬ÈéÏÙ°©¡£¡£¡£¡£¿ÉÒÔÏÈÕÒÕÒ×ÛÊö¿´¿´£¬ÈçNatureµÄ£¬CellµÄ£¬Cancer CellµÄ¡£
http://www.cancercell.org/°©Ï¸°û
http://www.annualreviews.org/institutions/resources.aspx ×ÛÊöÄ꿯
¡£¡£¡£
¡ª¡ª´©Ô½ËÀÍöÖ®ÃÅ£¬µ½ÎÒÕâÀïÀ´£¬ËäÔòÃÎÏëÍÊÉ«£¬ËêÔ¼¯³ÉµÄ¹ûʵ¸¯Àõô£¬µ«ÎÒÊÇÓÀºãµÄÕæÀí£¬Ä㽫ÔÙ»á¼ûÎÒ£¬ÔÚÄã´Ó´Ë°¶¶ÉÏò±Ë°¶µÄÉúÃüº½³ÌÖÐ...
5Â¥2008-01-17 12:43:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

asbaggio1977

½ð³æ (ÕýʽдÊÖ)

¼Ç²»Ì«Çå³þÁË£¬JMCÊÇACS£¬ÁíÍâµÄ¿ÉÄÜÊÇWileyµÄ£¬»òÕßRCSµÄ¡£
±£³ÖÕæ³Ï£¡
6Â¥2008-01-17 12:46:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nucleus01

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

Сľ³æ±±Í¥½Ú¶Èʹ

¡ï ¡ï ¡ï ¡ï ¡ï
xjxlovelxl(½ð±Ò+2,VIP+0):Ŷ~~~ºÃ¶à°¡,ºÃ¸´ÔÓ°¡;)ллÄúµÄ°ïÖú£¡
Â¥À¼ÉÙÅ®(½ð±Ò+3,VIP+0):ȷʵ²»´í£¬¿ÉÒÔ¼ÓÉÏÔ­ÎÄ
www.pubmed.orgÃâ·ÑµÄÊý¾Ý¿â²éѯϵͳ£¬²»ÄÜÖ±½ÓÏÂÔØÎÄÏס£µ«¸²¸ÇµÄÊý¾Ý¿âºÍ¿¯ÎïºÜ¶à¡£¿ÉÒÔÓÃendnoteÖ±½ÓÁ¬½Ó²éѯ¡£ seicncedirect , wiley , springerlink ,proquestµÈ¶¼ÊÇ¿ÉÖ±½Ó²éѯÏÂÔØÎÄÏ×µÄÊý¾Ý¿â£¬ÏÂÔØÐèÒªÓÐȨÏÞ¡£
ÓÃanti-tumorΪ¹Ø¼ü´Ê ÔÚpubmedÖвéÁËЩ×ÛÊö£¬¹²23ƪ¡£Äã¿´¿´ÓÐûÓÐÓãº
1: Related Articles, LinksHadaschik BA, Gleave ME.

Therapeutic options for hormone-refractory prostate cancer in 2007.
Urol Oncol. 2007 Sep-Oct;25(5):413-9. Review.
PMID: 17826663 [PubMed - indexed for MEDLINE]2: Related Articles, LinksWoodworth T, Furst DE, Alten R, Bingham C, Yocum D, Sloan V, Tsuji W, Stevens R, Fries J, Witter J, Johnson K, Lassere M, Brooks P.

Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0.
J Rheumatol. 2007 Jun;34(6):1401-14.
PMID: 17552067 [PubMed - indexed for MEDLINE]3: Related Articles, LinksMacDonald JK, McDonald JW.

Natalizumab for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. Review.
PMID: 17253580 [PubMed - indexed for MEDLINE]4: Related Articles, LinksGartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN.

The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis.
J Rheumatol. 2006 Dec;33(12):2398-408. Review.
PMID: 17225293 [PubMed - indexed for MEDLINE]5: Related Articles, LinksMacdonald JK, McDonald JW.

Natalizumab for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2006 Jul 19;3:CD006097. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD006097.
PMID: 16856112 [PubMed - indexed for MEDLINE]6: Related Articles, LinksCurtin JF, King GD, Candolfi M, Greeno RB, Kroeger KM, Lowenstein PR, Castro MG.

Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
Curr Top Med Chem. 2005;5(12):1151-70. Review.
PMID: 16248789 [PubMed - indexed for MEDLINE]7: Related Articles, LinksAnolik JH, Aringer M.

New treatments for SLE: cell-depleting and anti-cytokine therapies.
Best Pract Res Clin Rheumatol. 2005 Oct;19(5):859-78. Review.
PMID: 16150407 [PubMed - indexed for MEDLINE]8: Related Articles, LinksBraun J, Baraliakos X, Listing J, Sieper J.

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
Arthritis Rheum. 2005 Aug;52(8):2447-51. Review.
PMID: 16052578 [PubMed - indexed for MEDLINE]9: Related Articles, LinksHomik JE, Suarez-Almazor M.

An economic approach to health care.
Best Pract Res Clin Rheumatol. 2004 Apr;18(2):203-18. Review.
PMID: 15121040 [PubMed - indexed for MEDLINE]10: Related Articles, LinksLi WP, Anderson CJ.

Imaging matrix metalloproteinase expression in tumors.
Q J Nucl Med. 2003 Sep;47(3):201-8. Review.
PMID: 12897711 [PubMed - indexed for MEDLINE]11: Related Articles, LinksMaksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC).

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
J Rheumatol. 2003 Jun;30(6):1356-63. Review.
PMID: 12784417 [PubMed - indexed for MEDLINE]12: Related Articles, LinksCao Y, Cao R, Veitonmäki N.

Kringle structures and antiangiogenesis.
Curr Med Chem Anticancer Agents. 2002 Nov;2(6):667-81. Review.
PMID: 12678719 [PubMed - indexed for MEDLINE]13: Related Articles, LinksLovejoy DB, Richardson DR.

Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators.
Curr Med Chem. 2003 Jun;10(12):1035-49. Review.
PMID: 12678675 [PubMed - indexed for MEDLINE]14: Related Articles, LinksGrant S, Roberts JD.

The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy.
Drug Resist Updat. 2003 Feb;6(1):15-26. Review.
PMID: 12654284 [PubMed - indexed for MEDLINE]15: Related Articles, LinksBarnett KT, Malafa MP.

Complications of hepatic artery infusion: a review of 4580 reported cases.
Int J Gastrointest Cancer. 2001;30(3):147-60. Review.
PMID: 12540027 [PubMed - indexed for MEDLINE]16: Related Articles, LinksKalos M.

Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects.
Vaccine. 2003 Jan 30;21(7-8):781-6. Review.
PMID: 12531359 [PubMed - indexed for MEDLINE]17: Related Articles, LinksJalkut MW, Reiter RE.

Role of prostate stem cell antigen in prostate cancer research.
Curr Opin Urol. 2002 Sep;12(5):401-6. Review.
PMID: 12172427 [PubMed - indexed for MEDLINE]18: Related Articles, LinksMitchell MS.

Cancer vaccines, a critical review--Part I.
Curr Opin Investig Drugs. 2002 Jan;3(1):140-9. Review.
PMID: 12054065 [PubMed - indexed for MEDLINE]19: Related Articles, LinksBordignon C, Carlo-Stella C, Colombo MP, De Vincentiis A, Lanata L, Lemoli RM, Locatelli F, Olivieri A, Rondelli D, Zanon P, Tura S.

Cell therapy: achievements and perspectives.
Haematologica. 1999 Dec;84(12):1110-49. Review.
PMID: 10586214 [PubMed - indexed for MEDLINE]20: Related Articles, LinksAglietta M, Bertolini F, Carlo-Stella C, De Vincentiis A, Lanata L, Lemoli RM, Olivieri A, Siena S, Zanon P, Tura S.

Ex vivo expansion of hematopoietic cells and their clinical use.
21: Related Articles, LinksNatanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL.

Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis.
Ann Intern Med. 1994 May 1;120(9):771-83. Review.
PMID: 8147551 [PubMed - indexed for MEDLINE]22: Related Articles, LinksBodmer M, Fournel MA, Hinshaw LB.

Preclinical review of anti-tumor necrosis factor monoclonal antibodies.
Crit Care Med. 1993 Oct;21(10 Suppl):S441-6. Review.
PMID: 8403982 [PubMed - indexed for MEDLINE]23: Related Articles, LinksWherry JC, Pennington JE, Wenzel RP.

Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies.
Crit Care Med. 1993 Oct;21(10 Suppl
ˬÊÇÒª¸¶³ö´ú¼ÛµÄ!
7Â¥2008-01-17 13:05:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xjxlovelxl

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

CA-FANS

ÇóÖúÇóÖú£¬×ö¹ýµÄ³æÓѰï°ï棡
¡¾¹«¸æ£ºÓн±ÎÊ´ð°æ½ûÖ¹¹àË®¡¿
8Â¥2008-01-17 16:52:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xjxlovelxl

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

CA-FANS

×ö¹ýµÄ³æÓѰï°ï棡
¡¾¹«¸æ£ºÓн±ÎÊ´ð°æ½ûÖ¹¹àË®¡¿
9Â¥2008-01-18 12:14:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sunnyjane

½ð³æ (СÓÐÃûÆø)

¡ï ¡ï ¡ï ¡ï ¡ï
xjxlovelxl(½ð±Ò+5,VIP+0):ллÄúµÄÖ¸µ¼£¬ÎÒÏÖÔÚÊ×ÏÈҪȷ¶¨¶ÔÄÄÖÖÁö×îÓÐЧ£¬ËùÒԲŻáÑ¡ÔñÐÔµÄÈ¥×öһЩϸ°û
¿ÉÒÔÓÃÀ´×öʵÑéµÄϸ°ûÖêÖÖÀà·Ç³£¶à£¬µ«Äã±ØÐëÑ¡ÔñÄãÒª×öµÄÒ©ÎïËùÕë¶ÔµÄÖ×Áö£¬Õâ¸öÒ©¶ÔÄÄÖÖÖ×Áö×îÓÐЧ£¬µ±È»Ó¦¸ÃÊ×Ñ¡ÄÄÖÖϸ°ûÁË£¬ÁíÍâÒ»°ã·Î°©Ï¸°ûºÍ¸Î°©Ï¸°û×îºÃÅàÑø£¬Òª×öÂãÊó½ÓÖֵϰ£¬³ÉÁöÂÊÒ²×î¸ß¡£Äã¿ÉÒÔÏȲéÒ»ÏÂÄãÒª×öµÄÒ©ÎïÖ÷ÒªÊÇÕë¶Ôʲô°©µÄÔÙÈ·¶¨±È½ÏºÃÀ²¡£ÎÒÃÇÒÔǰÓиöÒ©¾ÍÊÇÕë¶ÔÈé°©µÄ£¬ÓÃÈËÈ鰩ϸ°ûЧ¹û¾Í·Ç³£ºÃ£¬Ó÷ΰ©Ï¸°ûÒª²îһЩ£¬µ«ÊÇÈ鰩ϸ°û²»Ì«ÈÝÒ×ÅàÑø£¬½ÓÖֳɹ¦ÂÊÒ²Ô¶µÍÓڷΰ©Ï¸°û¡£
10Â¥2008-01-18 13:18:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xjxlovelxl µÄÖ÷Ìâ¸üÐÂ
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +5 ÕÅvvvv 2026-03-15 7/350 2026-03-21 19:23 by ColorlessPI
[¿¼ÑÐ] ¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á +11 ³Ô³Ô³Ô²ÅÓÐÒâÒå 2026-03-19 11/550 2026-03-21 18:23 by ѧԱ8dgXkO
[¿¼ÑÐ] 307Çóµ÷¼Á +3 ÓàÒâÇä 2026-03-18 3/150 2026-03-21 17:31 by ColorlessPI
[¿¼ÑÐ] 299Çóµ÷¼Á +4 ijijijijλ 2026-03-21 4/200 2026-03-21 16:30 by barlinike
[¿¼ÑÐ] 279Çóµ÷¼Á +5 ºìÒÂÒþ¹Ù 2026-03-21 5/250 2026-03-21 14:59 by lature00
[¿¼ÑÐ] 085601µ÷¼Á 358·Ö +3 zzzzggh 2026-03-20 4/200 2026-03-21 10:21 by luoyongfeng
[¿¼ÑÐ] һ־Ըɽ´ó07»¯Ñ§ 332·Ö ËÄÁù¼¶Òѹý ±¾¿ÆÉ½¶«Ë«·Ç Çóµ÷¼Á£¡ +3 ²»ÏëÀíÄã 2026-03-16 3/150 2026-03-21 03:59 by JourneyLucky
[¿¼ÑÐ] ³õʼ318·ÖÇóµ÷¼Á£¨Óй¤×÷¾­Ñ飩 +3 1911236844 2026-03-17 3/150 2026-03-21 02:33 by JourneyLucky
[¿¼ÑÐ] »ª¶«Ê¦·¶´óѧ-071000ÉúÎïѧ-293·Ö-Çóµ÷¼Á +3 Ñо¿ÉúºÎÑþÃ÷ 2026-03-18 3/150 2026-03-21 01:30 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁÏ305·ÖÇóµ÷¼Á +6 ÏëÉϰ¶µÄÀðÓã 2026-03-18 7/350 2026-03-21 01:03 by JourneyLucky
[¿¼ÑÐ] 274Çóµ÷¼Á +10 S.H1 2026-03-18 10/500 2026-03-20 23:51 by JourneyLucky
[¿¼ÑÐ] 324Çóµ÷¼Á +5 luckyѽѽѽѼ 2026-03-20 5/250 2026-03-20 22:30 by ´ÙÌì³É
[¿¼ÑÐ] Çóµ÷¼Á +3 @taotao 2026-03-20 3/150 2026-03-20 19:35 by JourneyLucky
[¿¼ÑÐ] ¹ãÎ÷´óѧ¼ÒÇÝÒÅ´«ÓýÖÖ¿ÎÌâ×é2026Äê˶ʿÕÐÉú£¨½ÓÊÕ¼ÆËã»úרҵµ÷¼Á£© +3 123°¢±ê 2026-03-17 3/150 2026-03-20 15:58 by ·ÉÐÐçù
[¿¼ÑÐ] 081700»¯¹¤Ñ§Ë¶µ÷¼Á +3 ¡¾1¡¿ 2026-03-16 3/150 2026-03-19 23:40 by edmund7
[¿¼ÑÐ] 328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑо­Àú +4 ÉúÎ﹤³Ìµ÷¼Á 2026-03-16 12/600 2026-03-19 11:10 by ÉúÎ﹤³Ìµ÷¼Á
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] ¿¼ÑÐÇóµ÷¼Á +3 éÙËÌ. 2026-03-17 4/200 2026-03-17 21:43 by ÓÐÖ»ÀêÅ«
[¿¼ÑÐ] 308Çóµ÷¼Á +4 ÊÇLupa°¡ 2026-03-16 4/200 2026-03-17 17:12 by ruiyingmiao
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û